Area of research
Cancer Research · Cellular and Molecular Neuroscience
Research interest
Research focused on Palonosetron and NK1 receptor antagonist, with related work in Prostate cancer, Metformin, Translocator protein. Notable publications include 'Biodistribution, Tumor Detection, and Radiation Dosimetry of 18 F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic...', 'Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer', and 'Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors'.
Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer
Regional brain distribution of translocator protein using [11C]DPA-713 PET in individuals infected with HIV
Mutant disrupted‐in‐schizophrenia 1 in astrocytes: Focus on glutamate metabolism
Molecular mechanisms of 5-HT3 and NK1 receptor antagonists in prevention of emesis
Biodistribution, Tumor Detection, and Radiation Dosimetry of <sup>18</sup>F-DCFBC, a Low-Molecular-Weight Inhibitor of Prostate-Specific Membrane Antigen, in Patients with Metastatic Prostate Cancer
Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors
Pharmacological mechanisms of 5-HT3 and tachykinin NK1 receptor antagonism to prevent chemotherapy-induced nausea and vomiting